Table 1.
List of some approved vaccines against COVID-19.
| Name of the candidate | Primary developers | Type of vaccine | Country of origin | Authorization/ Approval |
|---|---|---|---|---|
| Sputnik V | Gamaleya Research Institute, Acellena Contract Drug Research and Development | Recombinant adenovirus vaccine (rAd26 and rAd5) | Russia | Russia and more than 68 countries |
| EpiVacCorona | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology | Peptide vaccine | Russia | Belarus, Russia, Turkmenistan |
| Comirnaty (BNT162b2) | Pfizer, BioNTech; Fosun pharma | mRNA-based vaccine | Multinational | UK, Bahrain, Canada, Mexico, USA, Singapore, Oman, Saudi Arabia, Kuwait, EU, WHO and nearly 65 more nations |
| Spikevax (mRNA-1273) | Moderna, NIAID, BARDA | mRNA-based vaccine | USA | USA, Canada, EU, UK, WHO and 40 more nations |
| COVID-19 Vaccine AstraZeneca (AZD1222)/Covishield | The University of Oxford; AstraZeneca; IQVIA; Serum Institute of India; BARDA, OWS | Adenovirus vaccine | UK | UK, EU, India and 110 more nations |
| WIBP-CorV | Wuhan Institute of Biological Products; China National Pharmaceutical Group (Sinopharm) | Inactivated vaccine | China | China and Phillippines |
| CoronaVac | Sinovac | Inactivated vaccine | China | China, Indonesia, Brazil, Chile, Turkey, WHO and 40 more countries |
| BBIBP-CorV/NVSI-06–07 | Beijing Institute of Biological Products; China National Pharmaceutical Group (Sinopharm) | Inactivated vaccine | China | China, United Arab Emirates, Bahrain, WHO and 72 more nations |
| Covaxin (BBV152) | Bharat Biotech; ICMR; Ocugen; ViroVax | Whole-Virion Inactivated | India | India, Botswana, Estonia, Finland, Guatemala, Guyana, Hong Kong, WHO and 12 more nations |
| Convidicea (PakVac, Ad5-nCoV) | CanSino Biologics | Recombinant vaccine | China | China, Chile, Pakistan, Ecuador, Hungary and 6 more nations |
| COVID-19 Vaccine Janssen (JNJ-78436735) | Janessen Vaccines (Johnson & Johnson), BARDA, NIAID and OWS. | Non-replicating viral vector | The Netherlands, US | US, UK, EU, India, WHO, Saint Vincent and the Grenadines and 37 more nations |
| Sputnik Light | Gamaleya Research Institute, Acellena Contract Drug Research and Development | Recombinant adenovirus vaccine (rAd26) | Russia | Russia and 21 more nations |
| CoviVac | Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products | Inactivated vaccine | Russia | Russia and Belarus |
| NVX-CoV2373 | Novavax, CEPI, Serum Institute of India | Recombinant nanoparticle vaccine | US | Australia, Canada, European Union, South Korea, Philippines, India, Indonesia, Philippines, Singapore, Switzerland, UK, and WHO |
| ZyCoV-D | Zydus Cadila | DNA vaccine (Plasmid) | India | India |
| Spikogen (COVAX-19) | Vaxine Pty ltd.; CinnaGen | Monovalent recombinant protein vaccine | Iran | Iran |
| ZF2001 (ZIFIVAX) | Anhui Zhifei Longcom Biopharmaceutical, Institute of Microbiology of the Chinese Academy of Sciences | Recombinant vaccine | China, Uzbekistan | China, Uzbekistan, Pakistan, and Indonesia, |
| Abdala (CIGB 66) | Center for Genetic Engineering and Biotechnology | Protein subunit vaccine | Cuba | Cuba, Vietnam, St. Vincent & Grenadines, Venezuela, Vietnam, and Nicaragua |
| COVIran Barekat | Shifa Pharmed Industrial Group | Inactivated vaccine | Iran | Iran |
| QazVac (QazCovid-in) | Research Institute for Biological Safety Problems | Inactivated vaccine | Kazakhstan | Kazakhstan |
| Soberana 02/Soberana Plus | Finlay Institute of Vaccines; Pasteur Institute | Conjugate vaccine | Cuba, Iran | Cuba, Iran, Nicaragua, and Venezuela |
| MVC-COV1901 | Medigen Vaccine Biologics Corp.; Dynavax | Protein subunit vaccine | Taiwan | Taiwan and Paraguay |
| Turkovac (ERUCOV-VAC) | Health Institutes of Turkey | Inactivated vaccine | Turkey | Turkey |
| Corbevax | Biological E, Baylor College of Medicine, Dynavax, CEPI | Adjuvanted protein subunit vaccine | India, United States | India and Botswana |
| Noora | Baqiyatallah University of Medical Sciences | Recombinant protein vaccine | Iran | Iran |
| Covifenz (CoVLP) | Medicago; GSK; Dynavax | Plant-based adjuvant vaccine | Canada | Canada |
| VLA2001 | Valneva; UK National Institute for Health Research | Inactivated vaccine | France, United States | Bahrain; UK |
Source: Regulatory Affairs Professional Society. Craven J, Therapeutic Tracker. https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-therapeutics-tracker47.